You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunotherapy/Checkpoint Inhibitors

Showing 1 - 25 of 8,328
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Immune Checkpoint Inhibitors
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023

Checkpoint Inhibitors in Solid Tumors:Retrospective Real-world

Recruiting
  • Immunotherapy
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Feb 8, 2023

    Metastatic Extracranial Malignant Solid Tumor, Radiotherapy, Immune Checkpoint Blockade Trial in Shantou (Intestinal Low Dose

    Not yet recruiting
    • Metastatic Extracranial Malignant Solid Neoplasm
    • +3 more
    • Intestinal Low Dose Radiotherapy-1Gy
    • +3 more
    • Shantou, Guangdong, China
      Cancer Hospital, Shantou University Medical College
    Oct 7, 2023

    Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

    Recruiting
    • Immunotherapy
    • +5 more
    • blood retriewal
    • Amiens, Picardie, France
      CHU Amiens Picardie
    Apr 3, 2023

    Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

    Not yet recruiting
    • Esophageal Carcinoma
    • Immune Checkpoint Inhibitors
    • (no location specified)
    Jul 6, 2023

    Metastatic Cancer, Melanoma Cancer, Lung Cancer Trial in United States (Stereotactic Body Radiotherapy, Ipilimumab, Nivolumab,

    Recruiting
    • Metastatic Cancer
    • +5 more
    • Stereotactic Body Radiotherapy
    • Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
    • Hartford, Connecticut
    • +9 more
    Nov 17, 2022

    Pre-transplant ICI Exposure and Post-transplant Graft Rejection

    Recruiting
    • Graft Rejection
    • +3 more
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
    Jun 21, 2023

    Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune

    Recruiting
    • Metastatic Melanoma
    • +3 more
    • Immune checkpoint inhibitor
    • Ljubljana, Slovenia
      Institute of Oncology Ljubljana
    May 17, 2023

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Queen Mary Hospital
    Apr 10, 2023

    HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

    Not yet recruiting
    • HCC
    • Zabadinostat (CXD101) and Geptanolimab
    • Lenvatinib and Sorafenib
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Prince of Wales Hospital
    May 15, 2023

    NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

    Not yet recruiting
    • Non-small Cell Lung Cancer Stage III
    • radiotherapy
    • +3 more
    • (no location specified)
    Sep 10, 2023

    Breast Cancer, Colon Cancer, Lung Cancer Trial in Tucson (Automated Telephone Symptom Management (ATMS) and Telephone

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)
    • Active control comparator
    • Tucson, Arizona
      University of Arizona Cancer Center
    Feb 6, 2023

    Efficacy and Safety of ICIs as First-line Therapy for Advanced

    Not yet recruiting
    • Malignant Tumor
    • +2 more
      • Chongqing, Chongqing, China
        the second affiliated hospital of Army medical university
      May 16, 2023

      Toxicity and Symptom Burden in Chronic Cancer Survivors With

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +7 more
      • Assessment
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 6, 2022

      NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)

      Recruiting
      • Non-small Cell Lung Cancer
      • Rotterdam, Netherlands
        Erasmus MC
      Jun 5, 2023

      Genomic Data of American Indian Patient Population

      Active, not recruiting
      • Immune Checkpoint Inhibitors
      • +6 more
      • Immunotherapy
      • Tucson, Arizona
      • +5 more
      May 8, 2023

      Small Cell Lung Cancer, Immunotherapy Trial in Changsha (chronic psychological stress)

      Recruiting
      • Small Cell Lung Cancer
      • Immunotherapy
      • chronic psychological stress
      • Changsha, Hunan, China
        Department of Oncology, The Second Xiangya Hospital, Central Sou
      Jul 22, 2023

      Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)

      Recruiting
      • Cutaneous Melanoma
      • Blood sample
      • Cutaneous melanoma biopsy
      • Paris, Ile De France, France
        Dermatology department
      Oct 24, 2022

      Recurrent Cervical Carcinoma, Metastatic Cervical Carcinoma, Persistent Cervical Carcinoma Trial in Beijing (Tislelizumab plus

      Recruiting
      • Recurrent Cervical Carcinoma
      • +9 more
      • Tislelizumab plus radiotherapy
      • Beijing, Beijing, China
        Lei Li
      Apr 1, 2022

      Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

      Recruiting
      • Melanoma
      • Non-Small Cell Lung Cancer
      • Standard-of-care procedures
      • Study procedures
      • Amsterdam, Netherlands
      • +1 more
      Feb 28, 2022

      irAE Prediction of Anti-PD-1/L1 in Lung Cancer

      Recruiting
      • Immune Checkpoint Inhibitors
      • Lung Cancer
        • Beijing, China
          Peking Union Medical College Hospital
        Mar 31, 2022

        Non Small Cell Lung Cancer Metastatic Trial in Morgantown (Radiation, Immuno-Therapeutic Agent)

        Active, not recruiting
        • Non Small Cell Lung Cancer Metastatic
        • Radiation
        • Immuno-Therapeutic Agent
        • Morgantown, West Virginia
          WVU Cancer Institute - Mary Babb Randolph Cancer Center
        Apr 25, 2022

        Safety of ICIs and TKIs Therapy for HCC

        Recruiting
        • Hepatocellular Carcinoma
        • +2 more
        • Lenvatinib Oral Product
        • +2 more
        • Wuhan, Hubei, China
          Tongji Hospital, Tongji Medical College, Huazhong University of
        Jun 11, 2022

        Cancer Patients on Immune Checkpoint Inhibitors, DiRECT Study

        Recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • Malignant Solid Neoplasm
          • Alton, Illinois
          • +6 more
          May 18, 2022

          Melanoma, Lung Cancer Trial in Perugia (Systematic symptom assessment)

          Not yet recruiting
          • Melanoma
          • Lung Cancer
          • Systematic symptom assessment
          • Perugia, PG, Italy
            Oncologia Medica, Azienda Ospedaliera Universitaria
          Jun 9, 2021